 |
|
Prevalence of Abnormal Glucose Tolerance Following a Transient Ischemic Attack or Ischemic Stroke
Walter N. Kernan, MD;
Catherine M. Viscoli, PhD;
Silvio E. Inzucchi, MD;
Lawrence M. Brass, MD;
Dawn M. Bravata, MD;
Gerald I. Shulman, MD, PhD;
James C. McVeety, MD
Arch Intern Med. 2005;165:227-233.
Background Despite current preventive therapies, patients with transient ischemic attack (TIA) and ischemic stroke remain at high risk for recurrent brain disease and cardiovascular events. In an effort to develop new therapies, abnormal glucose tolerance has recently been proposed as an interventional target. Among persons not otherwise known to be diabetic, impaired glucose tolerance (IGT) and diabetic glucose tolerance (DGT) are each associated with an increased risk for incident vascular disease, vascular disease mortality, and all-cause mortality. We conducted this study to determine if IGT and DGT are sufficiently common among patients with TIA and ischemic stroke to warrant therapeutic trials of antihyperglycemic agents.
Methods Men and women older than 45 years were recruited from 3 hospitals in south central Connecticut. Eligibility criteria included a recent TIA or nondisabling ischemic stroke, no history of physician-diagnosed diabetes mellitus, and a fasting plasma glucose level less than 126 mg/dL (<7.0 mmol / L). After an overnight fast, subjects were admitted to a clinical research center for a standard 75-g oral glucose tolerance test. Impaired glucose tolerance was defined by a 2-hour plasma glucose value of 140 to 199 mg/dL (7.8-11.0 mmol / L) and DGT by a value of 200 mg/dL or greater ( 11.1 mmol/L).
Results Between June 2000 and August 2003, we enrolled 98 eligible patients. The average time from TIA or stroke to measurement of glucose tolerance was 105 days (range, 24-180 days) and the median age was 71 years. Twenty-seven subjects (28%) had IGT and 24 (24%) had diabetes. In a forward stepwise logistic regression model, only a fasting plasma glucose level of 110 mg/dL or greater (6.1 mmol / L) and lower waist circumference were associated with an increased risk for IGT or DGT.
Conclusions Impaired glucose tolerance and DGT are present in most persons with a recent TIA or ischemic stroke who have no history of diabetes and a fasting plasma glucose level less than 126 mg/dL (<7.0 mmol / L). Our findings bring new urgency to the initiation of research to examine the effectiveness of antihyperglycemic therapies among patients with cerebrovascular disease and abnormal glucose tolerance.
Author Affiliations: Departments of Internal Medicine (Drs Kernan, Viscoli, Inzucchi, Bravata, and Shulman), Neurology (Drs Brass and McVeety), Epidemiology and Public Health (Dr Brass), and Cellular & Molecular Physiology (Dr Shulman), Yale School of Medicine, New Haven, Conn; Veterans Affairs Connecticut Healthcare System, West Haven (Drs Brass and Bravata); and Howard Hughes Medical Institute, New Haven (Dr Shulman).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Hyperglycaemia in acute ischaemic stroke is associated with an increased 5-year mortality
Kostulas et al.
Age Ageing 2009;38:590-594.
ABSTRACT
| FULL TEXT
Definition and Evaluation of Transient Ischemic Attack: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists.
Easton et al.
Stroke 2009;40:2276-2293.
ABSTRACT
| FULL TEXT
Natural history of blood glucose within the first 48 hours after ischemic stroke
Wong et al.
Neurology 2008;70:1036-1041.
ABSTRACT
| FULL TEXT
Weight Loss After Stroke: A Population-Based Study From the Lund Stroke Register
Jonsson et al.
Stroke 2008;39:918-923.
ABSTRACT
| FULL TEXT
Blood Glucose and Cerebrovascular Disease in Nondiabetic Patients
Nielson and Fleming
ANGIOLOGY 2007;58:625-629.
ABSTRACT
The JBS-2 guidelines on prevention of cardiovascular disease in clinical practice: an opportunity missed
Jessani et al.
QJM 2007;100:121-124.
FULL TEXT
Impaired Glucose Tolerance Increases Stroke Risk in Nondiabetic Patients With Transient Ischemic Attack or Minor Ischemic Stroke
Vermeer et al.
Stroke 2006;37:1413-1417.
ABSTRACT
| FULL TEXT
Glucose Tolerance Testing in Patients Scheduled for Cardiovascular Surgery
Hoekstra et al.
SEMIN CARDIOTHORAC VASC ANESTH 2006;10:7-9.
ABSTRACT
Cost Analysis of Intensive Glycemic Control in Critically Ill Adult Patients
Krinsley and Jones
Chest 2006;129:644-650.
ABSTRACT
| FULL TEXT
Impaired glucose metabolism in patients with acute stroke and no previous diagnosis of diabetes mellitus
Vancheri et al.
QJM 2005;98:871-878.
ABSTRACT
| FULL TEXT
|
